Steve Mister on Regulatory Concerns, FDA and FTC Actions, and the Council for Responsible Nutrition’s 50th Year

Mapping The Nutraceuticals World

Dietary supplement issues discussed include:

• The drug exclusion rule in DSHEA and the impact on CBD, NAC, NMN, and other ingredients;
• FDA restructuring of the Human Foods Program and industry’s relationship with its regulators;
• FDA’s “Dietary Supplement Ingredient Directory”;
• CBD and potential for a regulatory fix through the Farm Bill, or other legislative packages;
• FTC notices sent to companies about claims substantiation and its Health Products Compliance Guidance;
• Counterfeit products imitating dietary supplement brands and the potential impact on consumer trust;
• Results from a consumer survey and efforts to cover dietary supplement costs in Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA).

Click here for the full story notes.